

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.68001375 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.31297327 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 4.31297327 |
| 4 | alpha-linolenic acid metabolic process (GO:0036109) | 4.31140521 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.30782363 |
| 6 | L-phenylalanine catabolic process (GO:0006559) | 4.30782363 |
| 7 | protein carboxylation (GO:0018214) | 4.28403211 |
| 8 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.28403211 |
| 9 | skin morphogenesis (GO:0043589) | 4.21068204 |
| 10 | adhesion of symbiont to host (GO:0044406) | 4.09642442 |
| 11 | negative regulation of fibrinolysis (GO:0051918) | 3.98160045 |
| 12 | sulfur amino acid catabolic process (GO:0000098) | 3.85542985 |
| 13 | plasma lipoprotein particle clearance (GO:0034381) | 3.84013022 |
| 14 | adhesion of symbiont to host cell (GO:0044650) | 3.78460337 |
| 15 | virion attachment to host cell (GO:0019062) | 3.78460337 |
| 16 | complement activation, alternative pathway (GO:0006957) | 3.74608767 |
| 17 | regulation of protein activation cascade (GO:2000257) | 3.71014279 |
| 18 | high-density lipoprotein particle remodeling (GO:0034375) | 3.70604587 |
| 19 | protein retention in ER lumen (GO:0006621) | 3.68961026 |
| 20 | reverse cholesterol transport (GO:0043691) | 3.68071564 |
| 21 | aromatic amino acid family catabolic process (GO:0009074) | 3.65421801 |
| 22 | barbed-end actin filament capping (GO:0051016) | 3.64862170 |
| 23 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.58690278 |
| 24 | regulation of complement activation (GO:0030449) | 3.58433776 |
| 25 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.56895856 |
| 26 | lysine metabolic process (GO:0006553) | 3.56889086 |
| 27 | lysine catabolic process (GO:0006554) | 3.56889086 |
| 28 | kynurenine metabolic process (GO:0070189) | 3.56010580 |
| 29 | endodermal cell differentiation (GO:0035987) | 3.55787524 |
| 30 | basement membrane organization (GO:0071711) | 3.53750360 |
| 31 | protein localization to endosome (GO:0036010) | 3.52338171 |
| 32 | cell adhesion mediated by integrin (GO:0033627) | 3.51458244 |
| 33 | bile acid biosynthetic process (GO:0006699) | 3.50870712 |
| 34 | glyoxylate metabolic process (GO:0046487) | 3.50164714 |
| 35 | urea cycle (GO:0000050) | 3.50114622 |
| 36 | urea metabolic process (GO:0019627) | 3.50114622 |
| 37 | cysteine metabolic process (GO:0006534) | 3.47060147 |
| 38 | regulation of fibrinolysis (GO:0051917) | 3.46826198 |
| 39 | regulation of early endosome to late endosome transport (GO:2000641) | 3.45527798 |
| 40 | cellular modified amino acid catabolic process (GO:0042219) | 3.42387893 |
| 41 | amino-acid betaine metabolic process (GO:0006577) | 3.40136959 |
| 42 | protein heterotrimerization (GO:0070208) | 3.39465375 |
| 43 | regulation of cholesterol homeostasis (GO:2000188) | 3.38488021 |
| 44 | stress fiber assembly (GO:0043149) | 3.38202028 |
| 45 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.37926770 |
| 46 | low-density lipoprotein particle clearance (GO:0034383) | 3.35480337 |
| 47 | regulation of triglyceride catabolic process (GO:0010896) | 3.34785477 |
| 48 | apoptotic cell clearance (GO:0043277) | 3.28188066 |
| 49 | plasma lipoprotein particle remodeling (GO:0034369) | 3.27586257 |
| 50 | protein-lipid complex remodeling (GO:0034368) | 3.27586257 |
| 51 | macromolecular complex remodeling (GO:0034367) | 3.27586257 |
| 52 | phospholipid efflux (GO:0033700) | 3.25944805 |
| 53 | regulation of cholesterol esterification (GO:0010872) | 3.25503009 |
| 54 | positive regulation of lipid catabolic process (GO:0050996) | 3.25419459 |
| 55 | negative regulation of cholesterol transport (GO:0032375) | 3.25217870 |
| 56 | negative regulation of sterol transport (GO:0032372) | 3.25217870 |
| 57 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.22641900 |
| 58 | nitrogen cycle metabolic process (GO:0071941) | 3.22611447 |
| 59 | collagen fibril organization (GO:0030199) | 3.18513787 |
| 60 | positive regulation of extracellular matrix organization (GO:1903055) | 3.18268512 |
| 61 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.16654407 |
| 62 | tryptophan catabolic process (GO:0006569) | 3.12425384 |
| 63 | indole-containing compound catabolic process (GO:0042436) | 3.12425384 |
| 64 | indolalkylamine catabolic process (GO:0046218) | 3.12425384 |
| 65 | peptidyl-proline hydroxylation (GO:0019511) | 3.11445107 |
| 66 | substrate-dependent cell migration (GO:0006929) | 3.11328629 |
| 67 | kidney mesenchyme development (GO:0072074) | 3.08578383 |
| 68 | cortical actin cytoskeleton organization (GO:0030866) | 3.08166846 |
| 69 | regulation of cholesterol storage (GO:0010885) | 3.06570589 |
| 70 | chondrocyte proliferation (GO:0035988) | 3.05516773 |
| 71 | endothelial cell chemotaxis (GO:0035767) | 3.03023350 |
| 72 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.02395214 |
| 73 | cholesterol efflux (GO:0033344) | 3.02178055 |
| 74 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.01282826 |
| 75 | metanephric mesenchyme development (GO:0072075) | 3.00699426 |
| 76 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.00208721 |
| 77 | homocysteine metabolic process (GO:0050667) | 2.99578861 |
| 78 | regulation of extracellular matrix disassembly (GO:0010715) | 2.99433992 |
| 79 | hyaluronan catabolic process (GO:0030214) | 2.98831558 |
| 80 | fibrinolysis (GO:0042730) | 2.96932254 |
| 81 | serine family amino acid catabolic process (GO:0009071) | 2.95299296 |
| 82 | bile acid metabolic process (GO:0008206) | 2.92799047 |
| 83 | tryptophan metabolic process (GO:0006568) | 2.92516711 |
| 84 | coenzyme catabolic process (GO:0009109) | 2.92353411 |
| 85 | keratan sulfate catabolic process (GO:0042340) | 2.91949619 |
| 86 | protein-lipid complex assembly (GO:0065005) | 2.91440195 |
| 87 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.91346158 |
| 88 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.89585936 |
| 89 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.89040671 |
| 90 | protein hydroxylation (GO:0018126) | 2.87085748 |
| 91 | collagen metabolic process (GO:0032963) | 2.86818565 |
| 92 | aspartate family amino acid catabolic process (GO:0009068) | 2.86106620 |
| 93 | positive regulation of blood coagulation (GO:0030194) | 2.84937609 |
| 94 | positive regulation of hemostasis (GO:1900048) | 2.84937609 |
| 95 | endocytic recycling (GO:0032456) | 2.84292193 |
| 96 | phospholipid homeostasis (GO:0055091) | 2.84169583 |
| 97 | semaphorin-plexin signaling pathway (GO:0071526) | 2.83862804 |
| 98 | ethanol oxidation (GO:0006069) | 2.83349683 |
| 99 | plasma lipoprotein particle assembly (GO:0034377) | 2.83009635 |
| 100 | triglyceride homeostasis (GO:0070328) | 2.82911449 |
| 101 | acylglycerol homeostasis (GO:0055090) | 2.82911449 |
| 102 | glutamate metabolic process (GO:0006536) | 2.82719511 |
| 103 | carnitine metabolic process (GO:0009437) | 2.82371811 |
| 104 | 2-oxoglutarate metabolic process (GO:0006103) | 2.82069641 |
| 105 | collagen catabolic process (GO:0030574) | 2.81595964 |
| 106 | cortical cytoskeleton organization (GO:0030865) | 2.79555942 |
| 107 | positive regulation of fatty acid oxidation (GO:0046321) | 2.78512018 |
| 108 | epoxygenase P450 pathway (GO:0019373) | 2.78361282 |
| 109 | alpha-amino acid catabolic process (GO:1901606) | 2.77971147 |
| 110 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.76589804 |
| 111 | complement activation (GO:0006956) | 2.76488229 |
| 112 | regulation of plasminogen activation (GO:0010755) | 2.76264615 |
| 113 | low-density lipoprotein particle remodeling (GO:0034374) | 2.74617689 |
| 114 | complement activation, classical pathway (GO:0006958) | 2.74611932 |
| 115 | alanine transport (GO:0032328) | 2.74557503 |
| 116 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.74319953 |
| 117 | protein-lipid complex subunit organization (GO:0071825) | 2.71804627 |
| 118 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.71802344 |
| 119 | positive regulation of coagulation (GO:0050820) | 2.71796868 |
| 120 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.70007826 |
| 121 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.69543016 |
| 122 | glycosphingolipid catabolic process (GO:0046479) | 2.69033875 |
| 123 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.67827573 |
| 124 | lipoprotein metabolic process (GO:0042157) | 2.67652791 |
| 125 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.67577840 |
| 126 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.67577840 |
| 127 | cellular amino acid catabolic process (GO:0009063) | 2.67410897 |
| 128 | regulation of triglyceride metabolic process (GO:0090207) | 2.67170023 |
| 129 | extracellular matrix disassembly (GO:0022617) | 2.66347854 |
| 130 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.66212246 |
| 131 | plasma lipoprotein particle organization (GO:0071827) | 2.65799106 |
| 132 | positive regulation of axon extension (GO:0045773) | 2.65743256 |
| 133 | Golgi transport vesicle coating (GO:0048200) | 2.65276005 |
| 134 | COPI coating of Golgi vesicle (GO:0048205) | 2.65276005 |
| 135 | positive regulation of fatty acid metabolic process (GO:0045923) | 2.65047489 |
| 136 | multicellular organismal macromolecule metabolic process (GO:0044259) | 2.64889298 |
| 137 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.64006736 |
| 138 | tooth mineralization (GO:0034505) | 2.63792300 |
| 139 | regulation of triglyceride biosynthetic process (GO:0010866) | 2.63401610 |
| 140 | mannose metabolic process (GO:0006013) | 2.63379213 |
| 141 | 4-hydroxyproline metabolic process (GO:0019471) | 2.60698995 |
| 142 | protein activation cascade (GO:0072376) | 2.59700841 |
| 143 | acute-phase response (GO:0006953) | 2.58411507 |
| 144 | cell-substrate junction assembly (GO:0007044) | 2.57982105 |
| 145 | cofactor catabolic process (GO:0051187) | 2.57669889 |
| 146 | glial cell migration (GO:0008347) | 2.56881511 |
| 147 | short-chain fatty acid metabolic process (GO:0046459) | 2.56595985 |
| 148 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.55874031 |
| 149 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.54572307 |
| 150 | multicellular organismal catabolic process (GO:0044243) | 2.54170819 |
| 151 | positive regulation of receptor recycling (GO:0001921) | 2.54065087 |
| 152 | chondroitin sulfate catabolic process (GO:0030207) | 2.54039081 |
| 153 | cell migration involved in heart development (GO:0060973) | 2.53937142 |
| 154 | negative regulation of smooth muscle cell migration (GO:0014912) | 2.51059450 |
| 155 | tachykinin receptor signaling pathway (GO:0007217) | 2.49026712 |
| 156 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.47812237 |
| 157 | multicellular organismal metabolic process (GO:0044236) | 2.46841836 |
| 158 | venous blood vessel morphogenesis (GO:0048845) | 2.46009017 |
| 159 | decidualization (GO:0046697) | 2.45267084 |
| 160 | negative regulation of fatty acid transport (GO:2000192) | 2.41148110 |
| 161 | serine transport (GO:0032329) | 2.41046599 |
| 162 | extracellular matrix assembly (GO:0085029) | 2.39370822 |
| 163 | type B pancreatic cell proliferation (GO:0044342) | 2.39156941 |
| 164 | glycosaminoglycan catabolic process (GO:0006027) | 2.38191003 |
| 165 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.37753833 |
| 166 | negative regulation of adherens junction organization (GO:1903392) | 2.37498023 |
| 167 | negative regulation of focal adhesion assembly (GO:0051895) | 2.37498023 |
| 168 | negative regulation of cell junction assembly (GO:1901889) | 2.37498023 |
| 169 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.37108245 |
| 170 | response to thyroid hormone (GO:0097066) | 2.36733586 |
| 171 | adherens junction assembly (GO:0034333) | 2.36240887 |
| 172 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 2.35944796 |
| 173 | glycolipid catabolic process (GO:0019377) | 2.35029286 |
| 174 | mesenchymal cell differentiation involved in renal system development (GO:2001012) | 2.34655908 |
| 175 | mesenchymal cell differentiation involved in kidney development (GO:0072161) | 2.34655908 |
| 176 | positive regulation of digestive system process (GO:0060456) | 2.33430164 |
| 177 | pinocytosis (GO:0006907) | 2.32122958 |
| 178 | cell-cell junction maintenance (GO:0045217) | 2.31702752 |
| 179 | epithelial cell-cell adhesion (GO:0090136) | 2.31491618 |
| 180 | cellular copper ion homeostasis (GO:0006878) | 2.31486272 |
| 181 | oligosaccharide catabolic process (GO:0009313) | 2.31141019 |
| 182 | L-serine transport (GO:0015825) | 2.30379245 |
| 183 | regulation of extracellular matrix organization (GO:1903053) | 2.29705420 |
| 184 | regulation of apoptotic cell clearance (GO:2000425) | 2.29158367 |
| 185 | glomerular basement membrane development (GO:0032836) | 2.28853415 |
| 186 | embryo implantation (GO:0007566) | 2.28848530 |
| 187 | hemidesmosome assembly (GO:0031581) | 2.28202401 |
| 188 | extracellular fibril organization (GO:0043206) | 2.27193813 |
| 189 | mating behavior (GO:0007617) | 2.25596791 |
| 190 | response to acidic pH (GO:0010447) | 2.25090266 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.53200825 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.66270732 |
| 3 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.24512144 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.06208049 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.71594349 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.06413993 |
| 7 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 3.06080762 |
| 8 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.76403026 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.45880625 |
| 10 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.24216166 |
| 11 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.23074536 |
| 12 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.17715671 |
| 13 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.14038670 |
| 14 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.05350333 |
| 15 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.03011153 |
| 16 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.95450827 |
| 17 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.76321763 |
| 18 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.71869074 |
| 19 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.68700600 |
| 20 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.68013255 |
| 21 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.65162041 |
| 22 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.61458260 |
| 23 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.55988742 |
| 24 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.53004305 |
| 25 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.48652673 |
| 26 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.45251795 |
| 27 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.44765479 |
| 28 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.42292646 |
| 29 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.41737981 |
| 30 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.39400261 |
| 31 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.38856616 |
| 32 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.35353195 |
| 33 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.34761647 |
| 34 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.34736047 |
| 35 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.33459981 |
| 36 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.32588098 |
| 37 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.32588098 |
| 38 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.32188968 |
| 39 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.31861634 |
| 40 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.28649225 |
| 41 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.27721072 |
| 42 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.26575312 |
| 43 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.26493219 |
| 44 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.23727597 |
| 45 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.22868560 |
| 46 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.22208502 |
| 47 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.21059492 |
| 48 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.20509957 |
| 49 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.20369490 |
| 50 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.18554377 |
| 51 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.18266051 |
| 52 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.17857936 |
| 53 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.17855992 |
| 54 | KDM2B_26808549_Chip-Seq_K562_Human | 1.17085743 |
| 55 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.14715111 |
| 56 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 1.13578783 |
| 57 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.12995608 |
| 58 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.12456598 |
| 59 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.12437279 |
| 60 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.12074750 |
| 61 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.09562019 |
| 62 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.06381503 |
| 63 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.06224233 |
| 64 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.05740411 |
| 65 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.04701071 |
| 66 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.04439236 |
| 67 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.02914184 |
| 68 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.02776733 |
| 69 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.02776733 |
| 70 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.02254934 |
| 71 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.02227644 |
| 72 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.02186248 |
| 73 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.01819469 |
| 74 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.99791888 |
| 75 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.99101483 |
| 76 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.98544408 |
| 77 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.98510393 |
| 78 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.98369657 |
| 79 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.98079781 |
| 80 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.97870560 |
| 81 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97608493 |
| 82 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.96835673 |
| 83 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.96150391 |
| 84 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.94964754 |
| 85 | ATF3_27146783_Chip-Seq_COLON_Human | 0.94264372 |
| 86 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.94091467 |
| 87 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.93997868 |
| 88 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.93741482 |
| 89 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.93703369 |
| 90 | * DROSHA_22980978_ChIP-Seq_HELA_Human | 0.93600136 |
| 91 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.92582895 |
| 92 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.92582895 |
| 93 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.92297457 |
| 94 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.91369115 |
| 95 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.91257091 |
| 96 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.90088239 |
| 97 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.89950320 |
| 98 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.89141561 |
| 99 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.88530598 |
| 100 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.87703317 |
| 101 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.86995301 |
| 102 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.86229854 |
| 103 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.85737614 |
| 104 | CJUN_26792858_Chip-Seq_BT549_Human | 0.85342439 |
| 105 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.85296672 |
| 106 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.84918156 |
| 107 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.84857080 |
| 108 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.84333474 |
| 109 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.83530590 |
| 110 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.82437037 |
| 111 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.82352890 |
| 112 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.81855110 |
| 113 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.81461423 |
| 114 | * SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.81433913 |
| 115 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.81131831 |
| 116 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.80958248 |
| 117 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.80703712 |
| 118 | * SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.79839043 |
| 119 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.79221787 |
| 120 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.78556041 |
| 121 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.78401118 |
| 122 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.78078205 |
| 123 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.77729955 |
| 124 | P68_20966046_ChIP-Seq_HELA_Human | 0.77224373 |
| 125 | GATA1_19941826_ChIP-Seq_K562_Human | 0.77057153 |
| 126 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.77048523 |
| 127 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.76547136 |
| 128 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.76199784 |
| 129 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.76198828 |
| 130 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.76157410 |
| 131 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.74502260 |
| 132 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.74394562 |
| 133 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.73846155 |
| 134 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.73771661 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 4.60531018 |
| 2 | MP0005360_urolithiasis | 4.26952872 |
| 3 | MP0009840_abnormal_foam_cell | 3.88372362 |
| 4 | MP0008438_abnormal_cutaneous_collagen | 3.79970897 |
| 5 | MP0003705_abnormal_hypodermis_morpholog | 3.45056593 |
| 6 | MP0005365_abnormal_bile_salt | 3.40841457 |
| 7 | MP0005085_abnormal_gallbladder_physiolo | 3.27216355 |
| 8 | MP0008875_abnormal_xenobiotic_pharmacok | 2.79603478 |
| 9 | MP0005083_abnormal_biliary_tract | 2.61430362 |
| 10 | MP0005058_abnormal_lysosome_morphology | 2.57454358 |
| 11 | MP0010329_abnormal_lipoprotein_level | 2.53063561 |
| 12 | MP0003191_abnormal_cellular_cholesterol | 2.52882821 |
| 13 | MP0003195_calcinosis | 2.38418863 |
| 14 | MP0003252_abnormal_bile_duct | 2.30668417 |
| 15 | MP0000604_amyloidosis | 2.24795836 |
| 16 | MP0005332_abnormal_amino_acid | 2.07190335 |
| 17 | MP0004858_abnormal_nervous_system | 2.03823223 |
| 18 | MP0003329_amyloid_beta_deposits | 2.03621745 |
| 19 | MP0002877_abnormal_melanocyte_morpholog | 2.03053234 |
| 20 | MP0003279_aneurysm | 2.02410023 |
| 21 | MP0006054_spinal_hemorrhage | 1.98254704 |
| 22 | MP0005275_abnormal_skin_tensile | 1.93599098 |
| 23 | MP0003806_abnormal_nucleotide_metabolis | 1.90439169 |
| 24 | MP0003172_abnormal_lysosome_physiology | 1.89392995 |
| 25 | MP0002254_reproductive_system_inflammat | 1.87996622 |
| 26 | MP0005670_abnormal_white_adipose | 1.72710787 |
| 27 | MP0005451_abnormal_body_composition | 1.64090086 |
| 28 | MP0002118_abnormal_lipid_homeostasis | 1.61171265 |
| 29 | MP0005508_abnormal_skeleton_morphology | 1.58307956 |
| 30 | MP0004233_abnormal_muscle_weight | 1.57146446 |
| 31 | MP0005409_darkened_coat_color | 1.56821441 |
| 32 | MP0000609_abnormal_liver_physiology | 1.55990661 |
| 33 | MP0001958_emphysema | 1.53765915 |
| 34 | MP0005319_abnormal_enzyme/_coenzyme | 1.50162626 |
| 35 | MP0003690_abnormal_glial_cell | 1.49533378 |
| 36 | MP0003075_altered_response_to | 1.46555252 |
| 37 | MP0004019_abnormal_vitamin_homeostasis | 1.45873568 |
| 38 | MP0000751_myopathy | 1.45786137 |
| 39 | MP0001666_abnormal_nutrient_absorption | 1.42360132 |
| 40 | MP0004130_abnormal_muscle_cell | 1.41788696 |
| 41 | MP0003566_abnormal_cell_adhesion | 1.39879671 |
| 42 | MP0005503_abnormal_tendon_morphology | 1.37250296 |
| 43 | MP0009384_cardiac_valve_regurgitation | 1.37099623 |
| 44 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.35820135 |
| 45 | MP0000534_abnormal_ureter_morphology | 1.31608953 |
| 46 | MP0009780_abnormal_chondrocyte_physiolo | 1.23609291 |
| 47 | MP0003300_gastrointestinal_ulcer | 1.23515087 |
| 48 | MP0003303_peritoneal_inflammation | 1.23256428 |
| 49 | MP0003436_decreased_susceptibility_to | 1.23170152 |
| 50 | MP0002089_abnormal_postnatal_growth/wei | 1.22393631 |
| 51 | MP0003656_abnormal_erythrocyte_physiolo | 1.22057234 |
| 52 | MP0005076_abnormal_cell_differentiation | 1.21503885 |
| 53 | MP0005623_abnormal_meninges_morphology | 1.19273842 |
| 54 | MP0001348_abnormal_lacrimal_gland | 1.18799773 |
| 55 | MP0003634_abnormal_glial_cell | 1.17394753 |
| 56 | MP0004272_abnormal_basement_membrane | 1.16469026 |
| 57 | MP0000920_abnormal_myelination | 1.15193225 |
| 58 | MP0003950_abnormal_plasma_membrane | 1.09473147 |
| 59 | MP0009643_abnormal_urine_homeostasis | 1.08002652 |
| 60 | MP0005023_abnormal_wound_healing | 1.07906524 |
| 61 | MP0002295_abnormal_pulmonary_circulatio | 1.07313828 |
| 62 | MP0005167_abnormal_blood-brain_barrier | 1.04702610 |
| 63 | MP0010386_abnormal_urinary_bladder | 1.04529535 |
| 64 | MP0002837_dystrophic_cardiac_calcinosis | 1.03556522 |
| 65 | MP0001915_intracranial_hemorrhage | 1.01727188 |
| 66 | MP0001533_abnormal_skeleton_physiology | 1.01387590 |
| 67 | MP0009764_decreased_sensitivity_to | 1.01292868 |
| 68 | MP0005197_abnormal_uvea_morphology | 1.00966697 |
| 69 | MP0005666_abnormal_adipose_tissue | 0.99038162 |
| 70 | MP0003453_abnormal_keratinocyte_physiol | 0.98301250 |
| 71 | MP0003448_altered_tumor_morphology | 0.98016825 |
| 72 | MP0002168_other_aberrant_phenotype | 0.97102559 |
| 73 | MP0000343_altered_response_to | 0.96862159 |
| 74 | MP0010368_abnormal_lymphatic_system | 0.96636393 |
| 75 | MP0004510_myositis | 0.93293705 |
| 76 | MP0003091_abnormal_cell_migration | 0.92918148 |
| 77 | MP0003011_delayed_dark_adaptation | 0.92266235 |
| 78 | MP0003045_fibrosis | 0.90958600 |
| 79 | MP0005166_decreased_susceptibility_to | 0.90034462 |
| 80 | MP0000858_altered_metastatic_potential | 0.89199872 |
| 81 | MP0000747_muscle_weakness | 0.88796447 |
| 82 | MP0002933_joint_inflammation | 0.88588481 |
| 83 | MP0001299_abnormal_eye_distance/ | 0.88254792 |
| 84 | MP0002269_muscular_atrophy | 0.86085233 |
| 85 | MP0002971_abnormal_brown_adipose | 0.86035150 |
| 86 | MP0002998_abnormal_bone_remodeling | 0.85796160 |
| 87 | MP0002090_abnormal_vision | 0.85644946 |
| 88 | MP0003942_abnormal_urinary_system | 0.84463257 |
| 89 | MP0000598_abnormal_liver_morphology | 0.83310017 |
| 90 | MP0000750_abnormal_muscle_regeneration | 0.83230734 |
| 91 | MP0003186_abnormal_redox_activity | 0.83153741 |
| 92 | MP0003879_abnormal_hair_cell | 0.81362163 |
| 93 | MP0006082_CNS_inflammation | 0.80790514 |
| 94 | MP0000733_abnormal_muscle_development | 0.80737322 |
| 95 | MP0008469_abnormal_protein_level | 0.80130145 |
| 96 | MP0005165_increased_susceptibility_to | 0.79883197 |
| 97 | MP0004087_abnormal_muscle_fiber | 0.79427429 |
| 98 | MP0002113_abnormal_skeleton_development | 0.79308021 |
| 99 | MP0001614_abnormal_blood_vessel | 0.79254541 |
| 100 | MP0001879_abnormal_lymphatic_vessel | 0.77847070 |
| 101 | MP0004883_abnormal_blood_vessel | 0.77795339 |
| 102 | MP0000163_abnormal_cartilage_morphology | 0.77492200 |
| 103 | MP0000767_abnormal_smooth_muscle | 0.77215670 |
| 104 | MP0005164_abnormal_response_to | 0.76601919 |
| 105 | MP0005464_abnormal_platelet_physiology | 0.76295777 |
| 106 | MP0001756_abnormal_urination | 0.75770994 |
| 107 | MP0003795_abnormal_bone_structure | 0.75344460 |
| 108 | MP0005171_absent_coat_pigmentation | 0.75048370 |
| 109 | MP0008961_abnormal_basal_metabolism | 0.74338201 |
| 110 | MP0002138_abnormal_hepatobiliary_system | 0.74014455 |
| 111 | MP0000749_muscle_degeneration | 0.73999097 |
| 112 | MP0005257_abnormal_intraocular_pressure | 0.73785761 |
| 113 | MP0001243_abnormal_dermal_layer | 0.72316903 |
| 114 | MP0001542_abnormal_bone_strength | 0.71735380 |
| 115 | MP0000249_abnormal_blood_vessel | 0.71534753 |
| 116 | MP0009763_increased_sensitivity_to | 0.70794868 |
| 117 | MP0002060_abnormal_skin_morphology | 0.70520260 |
| 118 | MP0002115_abnormal_skeleton_extremities | 0.69821129 |
| 119 | MP0005375_adipose_tissue_phenotype | 0.69483466 |
| 120 | MP0004084_abnormal_cardiac_muscle | 0.69323521 |
| 121 | MP0009250_abnormal_appendicular_skeleto | 0.69062533 |
| 122 | MP0009278_abnormal_bone_marrow | 0.67377834 |
| 123 | MP0005595_abnormal_vascular_smooth | 0.66782587 |
| 124 | MP0009115_abnormal_fat_cell | 0.66268867 |
| 125 | MP0000003_abnormal_adipose_tissue | 0.65550300 |
| 126 | MP0004859_abnormal_synaptic_plasticity | 0.64776576 |
| 127 | MP0000759_abnormal_skeletal_muscle | 0.64473164 |
| 128 | MP0002136_abnormal_kidney_physiology | 0.63634706 |
| 129 | MP0002909_abnormal_adrenal_gland | 0.62686461 |
| 130 | MP0002108_abnormal_muscle_morphology | 0.62508539 |
| 131 | MP0005330_cardiomyopathy | 0.62306750 |
| 132 | MP0002128_abnormal_blood_circulation | 0.61798494 |
| 133 | MP0008004_abnormal_stomach_pH | 0.61724660 |
| 134 | MP0005334_abnormal_fat_pad | 0.61712779 |
| 135 | MP0006138_congestive_heart_failure | 0.61658734 |
| 136 | MP0004036_abnormal_muscle_relaxation | 0.61602160 |
| 137 | MP0009642_abnormal_blood_homeostasis | 0.60952253 |
| 138 | MP0005390_skeleton_phenotype | 0.60403631 |
| 139 | MP0002896_abnormal_bone_mineralization | 0.60154100 |
| 140 | MP0009053_abnormal_anal_canal | 0.59578880 |
| 141 | MP0005193_abnormal_anterior_eye | 0.59313908 |
| 142 | MP0008874_decreased_physiological_sensi | 0.59190654 |
| 143 | MP0000678_abnormal_parathyroid_gland | 0.58908530 |
| 144 | MP0004947_skin_inflammation | 0.58592675 |
| 145 | MP0004185_abnormal_adipocyte_glucose | 0.58529202 |
| 146 | MP0001849_ear_inflammation | 0.58450173 |
| 147 | MP0001175_abnormal_lung_morphology | 0.57018750 |
| 148 | MP0008260_abnormal_autophagy | 0.55971856 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 4.97539441 |
| 2 | Xanthomatosis (HP:0000991) | 4.55458745 |
| 3 | Complement deficiency (HP:0004431) | 4.03592951 |
| 4 | Protrusio acetabuli (HP:0003179) | 3.88530969 |
| 5 | Hyperlipoproteinemia (HP:0010980) | 3.68091313 |
| 6 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.61640028 |
| 7 | Hypoalphalipoproteinemia (HP:0003233) | 3.49345461 |
| 8 | Systemic lupus erythematosus (HP:0002725) | 3.48033977 |
| 9 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.44654128 |
| 10 | Myocardial infarction (HP:0001658) | 3.44486541 |
| 11 | Premature rupture of membranes (HP:0001788) | 3.41372060 |
| 12 | Vascular tortuosity (HP:0004948) | 3.33304068 |
| 13 | Intrahepatic cholestasis (HP:0001406) | 3.27859939 |
| 14 | Abnormality of complement system (HP:0005339) | 3.21619269 |
| 15 | Axonal loss (HP:0003447) | 3.16242586 |
| 16 | Mucopolysacchariduria (HP:0008155) | 3.13407610 |
| 17 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.13407610 |
| 18 | Soft skin (HP:0000977) | 3.13043427 |
| 19 | Dysostosis multiplex (HP:0000943) | 3.09324435 |
| 20 | Arterial tortuosity (HP:0005116) | 3.06103977 |
| 21 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.98892801 |
| 22 | Atrophic scars (HP:0001075) | 2.96808734 |
| 23 | Bladder diverticulum (HP:0000015) | 2.96218974 |
| 24 | Prolonged partial thromboplastin time (HP:0003645) | 2.94419486 |
| 25 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.94084508 |
| 26 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.94084508 |
| 27 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.94084508 |
| 28 | Hyperammonemia (HP:0001987) | 2.82940889 |
| 29 | Spinal rigidity (HP:0003306) | 2.79399076 |
| 30 | Asymmetric septal hypertrophy (HP:0001670) | 2.77563088 |
| 31 | Peritonitis (HP:0002586) | 2.75975711 |
| 32 | Abnormality of the Achilles tendon (HP:0005109) | 2.75897953 |
| 33 | Wormian bones (HP:0002645) | 2.75806092 |
| 34 | Increased cerebral lipofuscin (HP:0011813) | 2.72614186 |
| 35 | Hypolipoproteinemia (HP:0010981) | 2.72440762 |
| 36 | Nuclear cataract (HP:0100018) | 2.69873641 |
| 37 | Cerebral aneurysm (HP:0004944) | 2.68571611 |
| 38 | Broad metatarsal (HP:0001783) | 2.66783136 |
| 39 | Joint hemorrhage (HP:0005261) | 2.64333026 |
| 40 | Abnormality of dentin (HP:0010299) | 2.61720880 |
| 41 | Fragile skin (HP:0001030) | 2.60167423 |
| 42 | Blue sclerae (HP:0000592) | 2.59691669 |
| 43 | Spondylolisthesis (HP:0003302) | 2.59012248 |
| 44 | Abnormality of the common coagulation pathway (HP:0010990) | 2.58565400 |
| 45 | Glomerulonephritis (HP:0000099) | 2.58448326 |
| 46 | Ketosis (HP:0001946) | 2.57669221 |
| 47 | Neonatal short-limb short stature (HP:0008921) | 2.57098128 |
| 48 | Follicular hyperkeratosis (HP:0007502) | 2.53138454 |
| 49 | Skin nodule (HP:0200036) | 2.51227459 |
| 50 | Genu recurvatum (HP:0002816) | 2.47399862 |
| 51 | Achilles tendon contracture (HP:0001771) | 2.45547614 |
| 52 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.45099302 |
| 53 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.44521781 |
| 54 | Hypercholesterolemia (HP:0003124) | 2.44500126 |
| 55 | Cardiovascular calcification (HP:0011915) | 2.43292297 |
| 56 | Cervical subluxation (HP:0003308) | 2.42705170 |
| 57 | Amyloidosis (HP:0011034) | 2.40390370 |
| 58 | Abnormality of proline metabolism (HP:0010907) | 2.39304160 |
| 59 | Hydroxyprolinuria (HP:0003080) | 2.39304160 |
| 60 | Distal upper limb amyotrophy (HP:0007149) | 2.38606911 |
| 61 | Upper limb amyotrophy (HP:0009129) | 2.38606911 |
| 62 | Epidermoid cyst (HP:0200040) | 2.35992311 |
| 63 | Neurofibrillary tangles (HP:0002185) | 2.34819510 |
| 64 | Hyperextensible skin (HP:0000974) | 2.34690978 |
| 65 | Vascular calcification (HP:0004934) | 2.33686762 |
| 66 | Cholecystitis (HP:0001082) | 2.32603760 |
| 67 | Abnormal gallbladder physiology (HP:0012438) | 2.32603760 |
| 68 | Hyperglycinuria (HP:0003108) | 2.32168428 |
| 69 | Mitral stenosis (HP:0001718) | 2.31371827 |
| 70 | Loss of speech (HP:0002371) | 2.30508430 |
| 71 | Nephritis (HP:0000123) | 2.27838852 |
| 72 | Joint stiffness (HP:0001387) | 2.26107323 |
| 73 | Obstructive sleep apnea (HP:0002870) | 2.24877268 |
| 74 | Hypobetalipoproteinemia (HP:0003563) | 2.23821474 |
| 75 | Vertebral compression fractures (HP:0002953) | 2.21723718 |
| 76 | Slender build (HP:0001533) | 2.20937811 |
| 77 | Abnormality of glycolipid metabolism (HP:0010969) | 2.20932190 |
| 78 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.20932190 |
| 79 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.20932190 |
| 80 | Turricephaly (HP:0000262) | 2.19774009 |
| 81 | Cerebral inclusion bodies (HP:0100314) | 2.18927644 |
| 82 | Mitral regurgitation (HP:0001653) | 2.18386642 |
| 83 | Increased connective tissue (HP:0009025) | 2.18126285 |
| 84 | Hyperacusis (HP:0010780) | 2.17796137 |
| 85 | Joint laxity (HP:0001388) | 2.17684704 |
| 86 | Ovoid vertebral bodies (HP:0003300) | 2.16560231 |
| 87 | Dilatation of the ascending aorta (HP:0005111) | 2.15844891 |
| 88 | Ankle contracture (HP:0006466) | 2.15369826 |
| 89 | Abnormality of the intrinsic pathway (HP:0010989) | 2.13640348 |
| 90 | Increased variability in muscle fiber diameter (HP:0003557) | 2.12403714 |
| 91 | Vacuolated lymphocytes (HP:0001922) | 2.12004830 |
| 92 | Abnormality of glycine metabolism (HP:0010895) | 2.11689263 |
| 93 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.11689263 |
| 94 | Global brain atrophy (HP:0002283) | 2.10078089 |
| 95 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.08935570 |
| 96 | Hand muscle atrophy (HP:0009130) | 2.07073147 |
| 97 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.05854830 |
| 98 | Osteolytic defects of the hand bones (HP:0009699) | 2.05854830 |
| 99 | Protuberant abdomen (HP:0001538) | 2.05385291 |
| 100 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.05336068 |
| 101 | Abnormality of the acetabulum (HP:0003170) | 2.03145350 |
| 102 | Shallow orbits (HP:0000586) | 2.02812288 |
| 103 | Hyporeflexia of lower limbs (HP:0002600) | 2.02760095 |
| 104 | Natal tooth (HP:0000695) | 2.02013625 |
| 105 | Aortic aneurysm (HP:0004942) | 2.01806282 |
| 106 | Abnormality of methionine metabolism (HP:0010901) | 1.99904057 |
| 107 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.99758402 |
| 108 | Aortic dissection (HP:0002647) | 1.98452553 |
| 109 | Ectopia lentis (HP:0001083) | 1.97896435 |
| 110 | Hyperglycinemia (HP:0002154) | 1.97891784 |
| 111 | Cholelithiasis (HP:0001081) | 1.97866433 |
| 112 | Disproportionate tall stature (HP:0001519) | 1.97547154 |
| 113 | Sensorimotor neuropathy (HP:0007141) | 1.96472677 |
| 114 | Neonatal onset (HP:0003623) | 1.96435370 |
| 115 | Biconcave vertebral bodies (HP:0004586) | 1.95404329 |
| 116 | Ketoacidosis (HP:0001993) | 1.95392903 |
| 117 | Supranuclear gaze palsy (HP:0000605) | 1.93956325 |
| 118 | Esophageal varix (HP:0002040) | 1.92867023 |
| 119 | Mitral valve prolapse (HP:0001634) | 1.92828786 |
| 120 | Aneurysm (HP:0002617) | 1.91930196 |
| 121 | Hemorrhage of the eye (HP:0011885) | 1.90561459 |
| 122 | Aortic valve stenosis (HP:0001650) | 1.89523665 |
| 123 | Short nail (HP:0001799) | 1.89379904 |
| 124 | Abnormality of the lumbar spine (HP:0100712) | 1.88705366 |
| 125 | Elbow flexion contracture (HP:0002987) | 1.87819474 |
| 126 | Type 1 muscle fiber predominance (HP:0003803) | 1.86191441 |
| 127 | Bowel diverticulosis (HP:0005222) | 1.84899544 |
| 128 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.84665011 |
| 129 | Tetraparesis (HP:0002273) | 1.84573595 |
| 130 | Thin bony cortex (HP:0002753) | 1.84069420 |
| 131 | Beaking of vertebral bodies (HP:0004568) | 1.83695865 |
| 132 | Abnormal gallbladder morphology (HP:0012437) | 1.82465876 |
| 133 | J-shaped sella turcica (HP:0002680) | 1.81474729 |
| 134 | Broad face (HP:0000283) | 1.80891056 |
| 135 | Back pain (HP:0003418) | 1.80316559 |
| 136 | Status epilepticus (HP:0002133) | 1.79804510 |
| 137 | Renovascular hypertension (HP:0100817) | 1.77139225 |
| 138 | Ulnar bowing (HP:0003031) | 1.76728130 |
| 139 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.76347090 |
| 140 | Flared iliac wings (HP:0002869) | 1.75545525 |
| 141 | Overgrowth (HP:0001548) | 1.74664387 |
| 142 | Insomnia (HP:0100785) | 1.74636231 |
| 143 | Long toe (HP:0010511) | 1.73910367 |
| 144 | Coxa vara (HP:0002812) | 1.73907300 |
| 145 | Polycythemia (HP:0001901) | 1.73736471 |
| 146 | Hypoventilation (HP:0002791) | 1.72168746 |
| 147 | Abnormal delivery (HP:0001787) | 1.71418997 |
| 148 | Aortic regurgitation (HP:0001659) | 1.71070306 |
| 149 | Apathy (HP:0000741) | 1.70709403 |
| 150 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.70325338 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 4.67214926 |
| 2 | ERN1 | 4.44815548 |
| 3 | CDK12 | 3.29214758 |
| 4 | SIK1 | 2.99140609 |
| 5 | PKN2 | 2.92413558 |
| 6 | BCKDK | 2.51121513 |
| 7 | TTN | 2.17666776 |
| 8 | FGFR4 | 2.05926436 |
| 9 | EPHB1 | 2.03877691 |
| 10 | RIPK1 | 1.84366982 |
| 11 | PRPF4B | 1.79374217 |
| 12 | LATS2 | 1.76666229 |
| 13 | LMTK2 | 1.73224689 |
| 14 | BMX | 1.72648492 |
| 15 | DDR2 | 1.70450748 |
| 16 | CDC42BPA | 1.68204197 |
| 17 | KSR2 | 1.62429746 |
| 18 | TGFBR2 | 1.52357505 |
| 19 | PTK6 | 1.51643684 |
| 20 | LIMK1 | 1.47351108 |
| 21 | NTRK1 | 1.37640787 |
| 22 | PDGFRA | 1.29149778 |
| 23 | PTK2B | 1.27037795 |
| 24 | TBK1 | 1.25552787 |
| 25 | PAK6 | 1.21860761 |
| 26 | PTK2 | 1.18529808 |
| 27 | CAMK1D | 1.17814164 |
| 28 | AKT3 | 1.10391168 |
| 29 | ICK | 1.09815992 |
| 30 | PRKD2 | 1.09029616 |
| 31 | CAMKK1 | 1.08961288 |
| 32 | STK38 | 1.08528742 |
| 33 | FER | 1.07397641 |
| 34 | RET | 1.05653992 |
| 35 | MAP3K9 | 1.04626914 |
| 36 | BLK | 1.04274793 |
| 37 | LRRK2 | 1.02557701 |
| 38 | DAPK2 | 1.02327637 |
| 39 | SMG1 | 1.02279818 |
| 40 | TYK2 | 1.01863189 |
| 41 | JAK1 | 1.01756252 |
| 42 | PDGFRB | 1.01565854 |
| 43 | CAMK1G | 1.01383063 |
| 44 | ARAF | 1.01257645 |
| 45 | PHKG2 | 1.00323827 |
| 46 | PHKG1 | 1.00323827 |
| 47 | TAOK1 | 0.99874161 |
| 48 | TYRO3 | 0.99398666 |
| 49 | NME2 | 0.99243511 |
| 50 | MST1R | 0.98677940 |
| 51 | MAP3K11 | 0.98412051 |
| 52 | EPHA3 | 0.98312417 |
| 53 | MAP2K1 | 0.97213454 |
| 54 | WNK1 | 0.96630106 |
| 55 | SCYL2 | 0.93882814 |
| 56 | MAPKAPK3 | 0.93502219 |
| 57 | PIM2 | 0.89945117 |
| 58 | NEK6 | 0.88342078 |
| 59 | ABL2 | 0.88218623 |
| 60 | GRK7 | 0.87937440 |
| 61 | MAP3K10 | 0.87128017 |
| 62 | PDPK1 | 0.87101879 |
| 63 | PRKD3 | 0.85751591 |
| 64 | PDK4 | 0.84111203 |
| 65 | PDK3 | 0.84111203 |
| 66 | MAP3K7 | 0.81740378 |
| 67 | PAK2 | 0.80587674 |
| 68 | MAP2K3 | 0.79642742 |
| 69 | NEK9 | 0.77611753 |
| 70 | MARK2 | 0.77314394 |
| 71 | PAK3 | 0.77219749 |
| 72 | JAK2 | 0.76987268 |
| 73 | PAK4 | 0.76703726 |
| 74 | DMPK | 0.76505796 |
| 75 | ERBB4 | 0.76437232 |
| 76 | MAP2K4 | 0.76221806 |
| 77 | MAPK12 | 0.75723274 |
| 78 | MAP3K1 | 0.72191063 |
| 79 | DAPK3 | 0.71273707 |
| 80 | BRD4 | 0.70905243 |
| 81 | PIK3CG | 0.69258051 |
| 82 | MTOR | 0.68071971 |
| 83 | EEF2K | 0.65825701 |
| 84 | MOS | 0.65744206 |
| 85 | MAP3K13 | 0.65041961 |
| 86 | EPHB2 | 0.64522258 |
| 87 | MAP3K3 | 0.64179178 |
| 88 | RIPK4 | 0.63882709 |
| 89 | MET | 0.63251535 |
| 90 | MAPK7 | 0.62939029 |
| 91 | ROCK2 | 0.62252759 |
| 92 | PDK2 | 0.58458495 |
| 93 | PDK1 | 0.57450538 |
| 94 | MAP2K2 | 0.56216171 |
| 95 | PRKD1 | 0.55600301 |
| 96 | TESK1 | 0.55028976 |
| 97 | PRKCH | 0.54073316 |
| 98 | KDR | 0.53461215 |
| 99 | HIPK2 | 0.53250679 |
| 100 | TRPM7 | 0.51903621 |
| 101 | MAP3K2 | 0.51066051 |
| 102 | HCK | 0.49040178 |
| 103 | RPS6KL1 | 0.48879346 |
| 104 | RPS6KC1 | 0.48879346 |
| 105 | MARK1 | 0.47669400 |
| 106 | MYLK | 0.46112462 |
| 107 | MINK1 | 0.45318483 |
| 108 | EPHA2 | 0.43840725 |
| 109 | MATK | 0.43549141 |
| 110 | TAOK2 | 0.42839018 |
| 111 | PRKCZ | 0.42418844 |
| 112 | DYRK1B | 0.41509004 |
| 113 | SRC | 0.40859681 |
| 114 | MAP3K6 | 0.40687187 |
| 115 | CSF1R | 0.40679936 |
| 116 | RPS6KA2 | 0.40655325 |
| 117 | PRKG2 | 0.39989712 |
| 118 | ROCK1 | 0.39151943 |
| 119 | KIT | 0.38845891 |
| 120 | CDK15 | 0.38298024 |
| 121 | SIK2 | 0.38160143 |
| 122 | CAMK2G | 0.37244094 |
| 123 | PRKACG | 0.37061549 |
| 124 | GSK3A | 0.36732241 |
| 125 | NTRK3 | 0.36497966 |
| 126 | CDK9 | 0.36450470 |
| 127 | IRAK3 | 0.35579572 |
| 128 | CDK11A | 0.35490678 |
| 129 | MAPK4 | 0.35258879 |
| 130 | SGK3 | 0.33897750 |
| 131 | LATS1 | 0.33291590 |
| 132 | CDK18 | 0.32495910 |
| 133 | ZAP70 | 0.30536891 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.57260805 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.36323630 |
| 3 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.31856550 |
| 4 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.72783707 |
| 5 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.59448689 |
| 6 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.47934101 |
| 7 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.38090133 |
| 8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.18719954 |
| 9 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.12234430 |
| 10 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.08164999 |
| 11 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.01091960 |
| 12 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.90834580 |
| 13 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.90304406 |
| 14 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.89188703 |
| 15 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.88999466 |
| 16 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.74981606 |
| 17 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.70988989 |
| 18 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.69158870 |
| 19 | Bile secretion_Homo sapiens_hsa04976 | 1.62707178 |
| 20 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.60555704 |
| 21 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.56829446 |
| 22 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.54684410 |
| 23 | Peroxisome_Homo sapiens_hsa04146 | 1.35395418 |
| 24 | Lysosome_Homo sapiens_hsa04142 | 1.32948922 |
| 25 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.32305796 |
| 26 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.31635725 |
| 27 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.30501059 |
| 28 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.29880070 |
| 29 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.27490895 |
| 30 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.25085620 |
| 31 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.24624555 |
| 32 | Carbon metabolism_Homo sapiens_hsa01200 | 1.20372956 |
| 33 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.15048252 |
| 34 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.13866362 |
| 35 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.12623825 |
| 36 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.10657451 |
| 37 | Histidine metabolism_Homo sapiens_hsa00340 | 1.09001009 |
| 38 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.06170672 |
| 39 | Adherens junction_Homo sapiens_hsa04520 | 1.01127355 |
| 40 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.00707327 |
| 41 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.00037048 |
| 42 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.99935880 |
| 43 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.98439806 |
| 44 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.98367131 |
| 45 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.97636099 |
| 46 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.95251691 |
| 47 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.95077256 |
| 48 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.94952603 |
| 49 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.94712986 |
| 50 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.94515094 |
| 51 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.94029610 |
| 52 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.93104165 |
| 53 | Other glycan degradation_Homo sapiens_hsa00511 | 0.91677079 |
| 54 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.91184552 |
| 55 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.90955744 |
| 56 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.90014011 |
| 57 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.89178913 |
| 58 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.87728431 |
| 59 | Salmonella infection_Homo sapiens_hsa05132 | 0.87266214 |
| 60 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.85641428 |
| 61 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.85059859 |
| 62 | Prion diseases_Homo sapiens_hsa05020 | 0.84241993 |
| 63 | ABC transporters_Homo sapiens_hsa02010 | 0.83417340 |
| 64 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.83369748 |
| 65 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.83001752 |
| 66 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.82794770 |
| 67 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.82527764 |
| 68 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.81944962 |
| 69 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.81531431 |
| 70 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.81351531 |
| 71 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.80602823 |
| 72 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.80125014 |
| 73 | Retinol metabolism_Homo sapiens_hsa00830 | 0.80078341 |
| 74 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.78226237 |
| 75 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.78040703 |
| 76 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.76614393 |
| 77 | Endocytosis_Homo sapiens_hsa04144 | 0.75650514 |
| 78 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.73835804 |
| 79 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.73188362 |
| 80 | Glioma_Homo sapiens_hsa05214 | 0.72692732 |
| 81 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.71914522 |
| 82 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.70613219 |
| 83 | Lysine degradation_Homo sapiens_hsa00310 | 0.70026805 |
| 84 | Sulfur relay system_Homo sapiens_hsa04122 | 0.69490682 |
| 85 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.69030777 |
| 86 | Amoebiasis_Homo sapiens_hsa05146 | 0.68132277 |
| 87 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.67051209 |
| 88 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.66949729 |
| 89 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.66677824 |
| 90 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.66593655 |
| 91 | Cocaine addiction_Homo sapiens_hsa05030 | 0.66168753 |
| 92 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.65755585 |
| 93 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.65542610 |
| 94 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.65229313 |
| 95 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.65104494 |
| 96 | Insulin resistance_Homo sapiens_hsa04931 | 0.64673736 |
| 97 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.64332269 |
| 98 | Melanogenesis_Homo sapiens_hsa04916 | 0.63359101 |
| 99 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.63320779 |
| 100 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.62944292 |
| 101 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.62367563 |
| 102 | Gap junction_Homo sapiens_hsa04540 | 0.62281484 |
| 103 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.61514527 |
| 104 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.61402481 |
| 105 | Axon guidance_Homo sapiens_hsa04360 | 0.60453707 |
| 106 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.59863818 |
| 107 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.59715620 |
| 108 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.59710858 |
| 109 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.59253712 |
| 110 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.59095850 |
| 111 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.57265445 |
| 112 | Hepatitis C_Homo sapiens_hsa05160 | 0.57232783 |
| 113 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.55813311 |
| 114 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.55339033 |
| 115 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.54079383 |
| 116 | Prostate cancer_Homo sapiens_hsa05215 | 0.54001347 |
| 117 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.53801523 |
| 118 | Endometrial cancer_Homo sapiens_hsa05213 | 0.53765541 |
| 119 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.52792018 |
| 120 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.52425970 |
| 121 | Shigellosis_Homo sapiens_hsa05131 | 0.52097363 |
| 122 | Long-term potentiation_Homo sapiens_hsa04720 | 0.50957276 |
| 123 | Galactose metabolism_Homo sapiens_hsa00052 | 0.50875281 |
| 124 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.49859476 |
| 125 | Thyroid cancer_Homo sapiens_hsa05216 | 0.49707589 |
| 126 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.49238773 |
| 127 | Malaria_Homo sapiens_hsa05144 | 0.48937441 |
| 128 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.48417044 |
| 129 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.48384631 |
| 130 | Melanoma_Homo sapiens_hsa05218 | 0.47965366 |
| 131 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.47794927 |
| 132 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.47783478 |
| 133 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.46214546 |
| 134 | GABAergic synapse_Homo sapiens_hsa04727 | 0.46178878 |
| 135 | Renin secretion_Homo sapiens_hsa04924 | 0.45969723 |
| 136 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.45744334 |
| 137 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.44195087 |
| 138 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.43620678 |
| 139 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.43273542 |
| 140 | Focal adhesion_Homo sapiens_hsa04510 | 0.39191549 |
| 141 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.38598841 |
| 142 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.38451009 |
| 143 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.38280514 |
| 144 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.36297223 |
| 145 | Phagosome_Homo sapiens_hsa04145 | 0.35676272 |
| 146 | Bladder cancer_Homo sapiens_hsa05219 | 0.35023216 |
| 147 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.32930519 |
| 148 | Tuberculosis_Homo sapiens_hsa05152 | 0.32262435 |
| 149 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.32260794 |
| 150 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.31412007 |
| 151 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.29377473 |
| 152 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.29097014 |
| 153 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.28371248 |
| 154 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.27316562 |
| 155 | Pertussis_Homo sapiens_hsa05133 | 0.27014755 |
| 156 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.25927823 |
| 157 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.25758203 |
| 158 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.25133674 |
| 159 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.24989797 |
| 160 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.24932982 |
| 161 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.24335104 |
| 162 | Leishmaniasis_Homo sapiens_hsa05140 | 0.23808884 |
| 163 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.23712077 |
| 164 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.23312872 |
| 165 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.23107739 |

